Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models

Background: Several strategies based on immune checkpoint inhibitors (ICIs) have been developed for cancer therapy, opening to advantages in cancer outcomes. However, several ICI-induced side effects have emerged in these patients, especially a rare but clinically significant cardiotoxicity with hig...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pers Med
Egile Nagusiak: Quagliariello, Vincenzo, Passariello, Margherita, Rea, Domenica, Barbieri, Antonio, Iovine, Martina, Bonelli, Annamaria, Caronna, Antonietta, Botti, Gerardo, De Lorenzo, Claudia, Maurea, Nicola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711520/
https://ncbi.nlm.nih.gov/pubmed/33086484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm10040179
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak